Neurogene's total assets for Q1 2025 were $315.30M, a decrease of -6.08% from the previous quarter. NGNE total liabilities were $23.51M for the fiscal quarter, a -7.29% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.